Barts Health NHS Trust selects Hyland’s ECM solution
OnBase is expected to reduce the cost and physical space required for storing paper patient records and to provide the workflow to streamline document-based processes. Bart’s Health NHS
Teva Pharmaceuticals International and Polpharma Biologics have signed a global licensing agreement for a proposed biosimilar to Ocrevus (ocrelizumab) to treat multiple sclerosis (MS).